Table 1: Baseline characteristics of
study population.
|
Parameters |
Overall
patients with Atrial Fibrillation (n
=32)(%) |
|
Age
(Mean±SD) years |
59.93±13.81
|
|
Female |
15 (46.9) |
|
Male |
17
(53.1) |
|
Body
Mass Index ( Mean) (Kg/m2) |
24.25 |
|
Medical
History |
|
|
Chest
Pain |
3
(9.3) |
|
Palpitations |
6
(18.8) |
|
Shortness
of Breath |
3
(9.3) |
|
Hypertension |
5
(15.6) |
|
Smoker |
3
(9.3) |
|
COVID-19
patients |
2
(6.2) |
|
Diabetic |
3
(9.3) |
|
Coronary
Artery Disease |
7
(21.8) |
|
History
of Medications |
|
|
Subjects
on Anti-Coagulant Drugs |
16
(50) |
|
Subjects
on Diuretics Drugs |
12
(37.5) |
|
Subjects
on Antacid |
9
(28.1) |
|
Subjects
on Anti-Hypertensive Drugs |
13
(40.6) |
|
Subjects
on Anti-Anginal Drugs |
3
(9.3) |
|
Subjects
on Anti-Hyperlipidemic Drugs |
8
(25) |
|
Subjects
on Hyperglycemic Drugs |
3
(9.3) |